1	Mujer	mujer	NCFS000	C0043210#C0015780#C0086418	persona#hallazgo#estructura_corporal#organismo_vivo	0-5	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
2	de	de	SPS00	C0332285	atributo	6-8	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
3	37	37		-	-	9-11	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
4	años	año	NCMP000	C0439234	calificador	12-16	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
5	afecta	afectar	VMIP3S0	-	-	17-23	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
6	de	de	SPS00	C0332285	atributo	24-26	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
7	una	una		C0205447_1	calificador_1	27-30	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
8	colitis	colitis	NCFN000	C0009324#C2919828_1	trastorno_1	31-38	232_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
9	ulcerosa	ulceroso	AQ0FS0	C0009324#C2919828_2	trastorno_2	39-47	232_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	8	1084	Modif
10	extensa	extenso	AQ0FS0	-	-	48-55	232_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	8	1084	Modif
11	,	,	Fc	-	-	55-56	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
12	presenta	presentar	VMIP3S0	-	-	57-65	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
13	un	un		C0205447_1	calificador_1	66-68	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
14	brote	brote	NCMS000	-	-	69-74	232_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-	-	-	-
15	grave	grave	AQ0CS0	C0439808#C0205082	calificador	75-80	232_QUEST_clinical_caseMIR	SENT1	B-Calificador	-	14	1084	Modif
16	por	por	SPS00	C0678226	atributo	81-84	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
17	el	el	DA0MS0	-	-	85-87	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
18	que	que	PR0CN000	-	-	88-91	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
19	se	se	P00CN000	-	-	92-94	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
20	inicia	iniciar	VMIP3S0	-	-	95-101	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
21	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	102-113	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
22	con	con	SPS00	C0332287	atributo	114-117	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
23	prednisona	prednisona	NCFS000	C0032952	sustancia	118-128	232_QUEST_clinical_caseMIR	SENT1	B-Grp_Medicamento	-	-	-	-
24	en	en	SPS00	C1720294#C0332285	calificador#atributo	129-131	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
25	dosis	dosis	NCFN000	-	-	132-137	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
26	de	de	SPS00	C0332285	atributo	138-140	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
27	1	1	Z	-	-	141-142	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
28	mg	mg	NCMN000	-	-	143-145	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
29	/	/	Fh	-	-	145-146	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
30	kg	kilogramo	NCMN000	C0439209	calificador	146-148	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-
31	.	.	Fp	-	-	148-149	232_QUEST_clinical_caseMIR	SENT1	-	-	-	-	-

1	Tras	tras	SPS00	-	-	150-154	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
2	una	una		C0205447_1	calificador_1	155-158	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
3	semana	semana	NCFS000	C0439230	calificador	159-165	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
4	de	de	SPS00	C0332285	atributo	166-168	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
5	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	169-180	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
6	,	,	Fc	-	-	180-181	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
7	la	el	DA0FS0	-	-	182-184	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
8	paciente	paciente	NCCS000	C0030705	persona	185-193	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
9	no	no	RN	C1298908	calificador	194-196	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
10	presenta	presentar	VMIP3S0	-	-	197-205	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
11	mejoría	mejoría	NCFS000	-	-	206-213	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-
12	.	.	Fp	-	-	213-214	232_QUEST_clinical_caseMIR	SENT2	-	-	-	-	-

1	¿	¿	Fia	-	-	215-216	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
2	Cuál	cuál	PT0CS000	-	-	216-220	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
3	es	ser	VSIP3S0	-	-	221-223	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
4	la	el	DA0FS0	-	-	224-226	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
5	siguiente	siguiente	AQ0CS0	C0332282	atributo	227-236	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
6	medida	medida	NCFS000	C0079809	atributo	237-243	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
7	terapéutica	terapéutico	AQ0FS0	-	-	244-255	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
8	a	a	SPS00	-	-	256-257	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
9	realizar	realizar	VMN0000	-	-	258-266	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
10	?	?	Fit	-	-	266-267	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-
11	.	.	Fp	-	-	267-268	232_QUEST_clinical_caseMIR	SENT3	-	-	-	-	-

